BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Company News  |  Deals

Archimedes, Pharmalink deal

Pharmalink received exclusive, worldwide rights to use Archimedes' Targit drug delivery technology for use with Nefecon to treat IgA nephropathy. Pharmalink, which was co-developing Nefecon with Pharmalink under a 2004...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >